| Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa | 37 | basilisk-x | | | | |
| Wow!! Nasal vaccin - Washington University and OCGN | 19 | Bossie81 | | | | |
| Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock | 11 | basilisk-x | | | | |
| Offering. no big deal - thoughts? | 5 | Bossie81 | | | | |
| Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock | 5 | basilisk-x | | | | |
| Hold or sell? | 3 | Secure_Cat_4646 | | | | |
| -💡WEEKLY DISCUSSION- | 1 | AutoModerator | | | | |
| Earnings call 07/08/24 | 1 | SeanR91 | | | | |
StoryNote